Cargando...
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
INTRODUCTION: Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in studies of pemphigus vulgaris, but data of pemphigoid diseases are limited. OBJECTIVE: To assess the effectiveness and safety...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827539/ https://ncbi.nlm.nih.gov/pubmed/29520266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00248 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|